Introduction
Chronic Granulomatous Disease (CGD) is an inherited immunodeficiency caused by mutations in genes encoding the main components of the phagocyte NADPH oxidase (NOX2) ,gp91 phox , p22 phox , p47 phox , p67 phox , and rarely p40 phox , resulting in impaired production of superoxide anion and other reactive oxygen intermediates. 1 Hemizygous mutations in gp91 phox cause the most common form, X-linked CGD (X-CGD), while autosomal CGD (A-CGD) is due to mutations in the other subunits. 2 CGD manifests clinically with recurrent infections and granulomatous complications. 3 Lower levels of residual ROS production by neutrophils are associated with earlier mortality. 2 Significantly elevated production of pro-inflammatory mediators by CGD myeloid cells (e.g., IL-8 4 , LTB 4 5 ), and decreased neutrophil apoptosis 6 are also thought to contribute to the excessive inflammation secondary or independent of infection that is often seen in CGD.
Beyond a role in immune defense, increased inflammation with associated increased reactive oxygen species generated by a family of NOX proteins, NOX2, NOX1 and NOX4, have been implicated in the pathogenesis of cardiovascular disease and atherosclerosis. 7 NADPH oxidases contribute to the differentiation and migration of vascular smooth muscle cells, endothelial cell response to nitric oxide, and are highly expressed in atherosclerotic plaque. [8] [9] [10] [11] [12] Reduced NADPH oxidase activity may reduce vascular inflammation and thereby decrease susceptibility to atherosclerosis -a possibility that makes pharmacologic inhibition of NOX a potential target of therapy for cardiovascular diseases. 13 Mouse models of NOX deficiency have yielded conflicting results on atherosclerosis progression. [14] [15] [16] [17] [18] Pharmacologic inhibition of NOX in murine models has succeeded in reducing atherosclerosis progression. 19 Studies in gp91 phox and p47 phox -deficient human CGD subjects mediators by CGD myeloid cells (e.g., IL-8 4 , LTB 4 5 ), and decreased neutrophi il l ap ap pop op pto to osi si sis s s 6 6 6 ar are also thought to contribute to the excessive inflammation secondary or independent of infection h hat at t i i is s s of of ofte te ten n n s seen n n i i in n n CGD.
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To date, no studies have reported the effects of NOX2 deficiency in the coronary circulation. We investigated markers of inflammation and the prevalence of subclinical carotid and coronary atherosclerosis using noninvasive MRI and CT techniques in normal controls and patients with gp91 phox or p47 phox CGD.
Methods

Patients
Patients over 18 years of age with a clinical diagnosis of CGD and either gp91 phox or p47 phox deficiency and healthy volunteers in the same age range were enrolled from 2010-2014 in an IRB approved protocol (10-I-0029) conducted at the NIH Clinical Center. All subjects provided documented informed consent. CGD diagnoses were confirmed by genetic sequencing and/or western blotting as well as quantitation of reactive oxygen species. 2 
Acquisition and Analysis of Carotid MR Imaging
Carotid wall volume was determined to assess the extent of atherosclerotic disease. 23 ICA wall volume was quantified using QPlaque (version 1.0, Medis) by a blinded observer. The area within the external boundary of the vessel and the arterial lumen were semiautomatically contoured on post-contrast T1 images, using pre-contrast T1 and T2 weighted images to confirm vessel boundaries in slices with flow artifact. 24, 25 The corresponding volume was obtained by multiplying the area in each image by the slice thickness and summing the total number of slices obtained. Wall volume was calculated by subtracting lumen volume from total vessel volume.
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Acquisition and Analysis of Cardiac CT Angiography
Coronary artery wall volume and calcium score were determined using CT angiography as measures of atherosclerotic disease. 26 Pre-and post-contrast CT imaging was performed using a 320-detector row scanner with slice thickness 0.5 mm (Aquilion ONE, Toshiba Medical Systems). Calcium scoring was performed with prospective ECG gating with 350 msec gantry rotation, 120 kV tube voltage and 300 mA tube current and quantified by the Agatston method. 27 CT angiography was performed after administration of intravenous iopamidol (Isovue 370, Bracco Diagnostics) using 120 kV tube voltage and tube current 350-580 mA dependent on BMI. Beta-blockers were administered if the resting heart rate was >60 beats per minute.
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Image analysis was performed on a Vitrea FX workstation (Version 6.1, Vital Images).
The left main coronary artery and proximal coronary artery segments were segmented according to previously published definitions. 28 The lumen and external vessel wall were semiautomatically contoured at 0.5 mm intervals. The area between the lumen and external wall was multiplied by slice thickness and summed over the total number of slices per segment to calculate coronary arterial wall volume (mm 3 ). Coronary artery wall volume was indexed to segment length to account for variability in coronary anatomy. The resulting value is reported as the coronary plaque index (mm 2 ). Inter-reader reproducibility for this method in a sub-sample of 10 consecutive participants was excellent (ICC=0.97).
Plasma Analytes
Glucose, lipids, and biomarker measurements were obtained after 12 hour fasting. Biomarker analysis was on plasma prepared from heparinized blood by 2 centrifugation steps at 500 g for 10 min. Plasma aliquots were stored in the vapor phase of liquid N 2 freezer prior to analysis. IL-1 , 
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Statistical Analysis
Continuous outcomes were summarized using means and standard deviations (SDs) or medians and interquartile ranges (IQRs) as appropriate, while counts and percentage values were reported for binary outcomes. Continuous outcomes of different subgroups were compared using t-tests with unequal variances. Binary outcomes were compared by chi-squared test. Spearman's correlation coefficient was used to summarize the correlation between two continuous outcomes.
Univariable and multivariable linear regression models were used to evaluate the unadjusted and adjusted effects of potential risk factors on carotid wall volume and coronary plaque burden. Two multivariable linear regression models were constructed: a base model adjusted for age and gender, and a second model including traditional clinical cardiovascular risk factors.
Coefficients of determination R 2 were reported to summarize the predictive power of a regression model. Carotid wall volume measures were logarithmically transformed (on a common log scale) before analysis to reduce skewness. Data analyses were carried out using STATA 10.1 (College Station, TX). All p values were two-sided and were not adjusted for multiple comparisons given the exploratory nature of this study. Graphpad Prism version 6.0d was used for ANOVA with a Holm-Šídák post-test 29 . P values less than 0.05 were considered statistically significant. with unequal variances. Binary outcomes were compared by chi-squared test. Sp pe e earm rm r an an a 's 's 's correlation coefficient was used to summarize the correlation between two continuous outcomes. 
Results
Patients
Twenty-two CGD patients with mutations in gp91 phox , 19 patients with mutations in p47 phox and 25 age-matched healthy controls were enrolled. Demographic and clinical characteristics of the study population are shown in Table 1 . CGD patients were 32.5 ± 9.4 years old and 76% were male. CGD patients had significantly elevated cardiovascular risk factors compared with controls, including more prevalent hypertension, decreased HDL-c, as well as increased oxidized LDL. Amongst CGD patients, those with p47 phox mutations had significantly greater residual superoxide production than those with gp91 phox mutations (3.0 ± 0.7 vs. 1.7 ± 1.8 nM superoxide/ 1 x 10 6 neutrophils/ 60 min respectively, p<0.01), about 1.3 % and 0.7% of superoxide produced by neutrophils from normal volunteers (226.29 ± 3.01 nM superoxide/1 x 10 6 neutrophils/60 min). 2
Plasma markers of inflammation in CGD
CGD subjects had higher levels of classical acute phase reactants (hsCRP) and innate defense proteins (myeloperoxidase, lactoferrin, and -defensins) suggesting increased neutrophil degranulation and systemic inflammation. Pro-inflammatory cytokines such as IL-6 and TNF as well as the chemokines CXCL8 (IL-8) and CCL4 (MIP1 ) were significantly elevated in CGD ( Table 1) . skewness the data were log-transformed prior to the statistical analyses that follow. The mean ± standard deviation of the common log-transformed ICA wall volume in CGD patients was 2.55 ± 0.02 log 10 mm 3 , compared with 2.66 ± 0.02 log 10 mm 3 in controls (p=0.0001, Table 2 & Figure   1A ). No participant in either group had evidence of atherosclerotic plaque that resulted in significant carotid luminal stenosis.
Subclinical Atherosclerosis
Internal Carotid Artery
There were significant univariate associations between ICA wall volume and CGD, HDL-c, IL-6, IL-10, IL-12p70 and IL-13. ( Significant univariable associations with coronary plaque were present for age and as significant predictors of ICA wall volume after controlling for traditional card dio i iova v v sc sc cul ul ular ar ar r r ri is isk factors in a multivariate linear regression model (R 2 R R = 0.50). 
Co
Subgroup Analyses
Amongst patients with CGD, those with deficiency in gp91 phox (X-linked CGD) were, as expected, entirely male while the p47 phox patients were evenly divided between men and women (47% male). TNF-levels were significantly lower in p47 phox patients. We otherwise observed no significant differences in prevalent traditional cardiovascular risk factors, lipid subfraction levels, or markers of systemic inflammation by genotype. (Table 5) As expected, in healthy control subjects the carotid artery wall volume was significantly lower in females compared with males (Fig 1B) . CGD gp91 phox deficient patients (all male) had significantly reduced carotid artery wall volume compared with age matched control males ( Figure 1B) . CGD p47 phox deficient male and female patients also had significantly reduced carotid artery wall volume compared with age and sex matched controls (Figure 1B) . There was no significant relationship between residual superoxide production and the internal carotid artery wall volume among all the CGD patients (not shown) nor was there a significant difference between common log-transformed internal carotid artery wall volume of p47 phox deficient and gp91 phox deficient patients (2.53 ± 0.02 vs. 2.57 ± 0.02 log 10 mm 3 , p=0. 19 ).
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As intraconazole has been demonstrated to affect HDL levels 30 we conducted a sensitivity analysis excluding 16 patients on active itraconazole prophylaxis therapy. The remaining 20 CGD patients still had a significant reduction in carotid atherosclerosis compared to healthy controls (p=0.0012).
Discussion
We decreased isoprostane formation and increased NO generation in X-CGD. 20 Increased flow mediated dilation was reported in p47 phox -deficient CGD patients but intimal-medial thickness did not differ from normal. 33 These results provided the first evidence in vivo that NOX2 may play a role in arterial tone and hypertension, and possibly contribute to the pathogenesis of atherosclerotic disease. 20, 22, 33 Although intimal-medial thickness is considered a useful surrogate marker for atherosclerosis, hypertension alone is a primary driver of intimal thickening, and can cause changes in carotid intimal-medial thickness that do not correspond histologically to atherosclerotic injury. 34 It is plausible that the observed reduction in carotid intimal-medial thickness was driven by NOX2 related improvement in endothelial function in a process independent of atherosclerosis. Flow mediated dilation provides useful insights into arterial endothelial function, but has not been demonstrated to predict future cardiovascular events beyond traditional risk factors. 35 The correlation between carotid and coronary atherosclerotic burden, while significant in some populations, has important limitations 36 , and it remains possible that the observed reduction in carotid intimal-medial thickness may not translate into a protective effect in other vascular beds consistent with previous observations in a mouse model. 37 While associations between morphologic carotid atherosclerosis and coronary arterial disease 38, 39 incident cardiovascular events have been observed, the presence and strength of these correlations varies importantly by population. 36 The present study demonstrates an association between both p47 phox and gp91 phox CGD and lower carotid wall thickness using histologically validated high-resolution MRI techniques. 25, 40 Our analysis shows this difference in early vascular injury is independent of hypertension, suggesting that it may be mediated through other NOX2 effects as discussed below. Importantly, p47 phox is not only a cytosolic regulator of NOX2 activity but can also regulate NOX1. 41 ndependent of atherosclerosis. Flow mediated dilation provides useful insights i int n nto o o ar r rte te eri ri rial al al endothelial function, but has not been demonstrated to predict future cardiovascular events be eyo yo yond nd nd t t tra ra adi di diti t tion nal al al r risk factors. 35 The correlation n n b b be et tween carotid d an a a d co co cor ro ronary atherosclerotic b bu urd rd den, while e si si ign gn gnif fic ic i an an nt t t in in in s s so om ome e po po popu pu ula ation n ns s, , ha as s i imp p po or orta tant nt n l lim im mit tat atio ion n ns 3 36 , , , a a an nd nd i i it t t re re ema main n ns s po poss ss ssib ib ible le l t tha ha hat t t th the e ob b bse ser r rve ed ed red ed duc uc cti ti tion on on i in n n ca ca aro ro rot t tid d d in in i t ti tim m mal l--me me med di dial al l t t thi hi ick ck kne ne n s ss ss m m may ay y n n not ot o t t tra ra ran nsl la late te e i in nt nto o a a This is the first study, to our knowledge, to examine the prevalence of subclinical coronary atherosclerosis in CGD. In contrast to the findings in the carotid arteries, noninvasive quantification of wall thickening and coronary plaque burden showed no significant difference between NOX2-deficient patients and controls. Quantification of coronary arterial calcium, a finding representative of more advanced atherosclerotic lesions and a powerful independent predictor of cardiovascular events, 35, 42 showed no reduction and a trend towards a greater burden of calcified atherosclerosis in CGD patients. Physiologically, it is possible that NOX2related mechanisms play a lesser role in coronary atherosclerosis than in other arterial beds.
While there was a non-statistically significant trend towards greater coronary calcification in CGD patients, the total volume of calcified and noncalcified plaque, as measured by coronary plaque index, was nearly identical to controls. The ratio of calcified to non-calcified components of atherosclerotic plaque varies in different disease processes, [43] [44] [45] and patients with CGD may have more rapid progression of calcification than found in typical atherosclerosis. We cannot exclude the possibility that small sample size limited the power to detect a smaller magnitude difference in coronary plaque burden between groups. Given the increases in the lifespan of CGD patients since the advent of antimicrobial prophylaxis, further investigation of the aging CGD population will likely reveal whether ROS play a role in calcified coronary atherosclerosis.
Our study of CGD patients also revealed significantly lower levels of HDL and a trend toward elevated triglycerides despite normal cholesterol. This is in contrast to the reported decrease in triglycerides in CGD mice. 14 itraconazole, which was been shown to reduce LDL and increase HDL in immunocompetent men. 30 We did not detect any association between itraconazole prophylaxis or other antibiotic therapies our patients were receiving and atherosclerotic burden or lipid profiles.
Despite the absence of overt signs of infection including normal white cell counts, plasma from CGD subjects in this study contained significantly increased concentrations of clinically recognized cardiovascular risk factors such as hsCRP 46 and MPO 47 as well as other inflammatory biomarkers (e.g., TNF , IL-6, GM-CSF). These elevations, which have not been reported previously in CGD, may be due to unrecognized infection or inflammation but may also relate to the direct regulatory role for reactive oxygen species in controlling inflammation. For example, ROS regulates the mRNA stability of IL8 4 , the metabolism of leukotrienes resulting in accumulation of LTB 4 5 , IL-1 processing 48 and the apoptosis of CGD neutrophils 6 . The role of cytokines as regulators of inflammation in cardiovascular disease has been reviewed 49 although specific pathophysiologic roles and clinical risk guidelines have yet to be established.
Interestingly, a common polymorphism in the IL-6 receptor that reduces function was associated in an 82-study meta-analysis with a decreased risk of coronary heart disease suggesting that signaling by IL-6, which was also elevated in CGD, may be pathogenic. 50 In parallel with MPO, we also observed significant elevations in CGD patient plasma of other neutrophil-derived factors including gelatinase, lactoferrin and defensins. Further work will be required to determine whether or not the increases in these factors are due to mechanisms such as those controlling IL- nterestingly, y, y a a a c c com om ommo mo mon n n po po oly ly lymo mo orp rp rphi hi hism sm m i in n n th th the e e IL IL IL-6 -6 6 r r rec e ep ep epto to or r th th that at at r red ed duc uc uces es es f f fun un unct ct tio io ion n n wa wa was s associated d d
Importantly, this finding also raises questions about whether or not NOX2 inhibitors may be beneficial in reducing all atherosclerosis or just that outside of the coronary circulation. Clearly, further high-resolution studies of possible links between deficiencies in or inhibition of different NOX proteins and atherogenesis in distinct anatomic vascular locations are indicated. Coeff is the estimated regression coefficient. SE is the variance of the estimated regression coefficient. 
